EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Digenic Congenital Hypogonadotropic Hypogonadism Due to Heterozygous GNRH1 p.R31C and AMHR2 p.G445_L453del Variants

Bronwyn G A Stuckey, Timothy W Jones, Bryan K Ward, Scott G Wilson iD

Genes · 2023

DOI: 10.3390/genes14061204 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, 2023. Verfasst von Bronwyn G A Stuckey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Keogh Institute for Medical Research, Nedlands, WA 6009, Australia. Hauptthemen laut MEDLINE: Gonadotropin-Releasing Hormone, Hypogonadism. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 28-year-old man with congenital hypogonadotropic hypogonadism (CHH) was found to be heterozygous for the GNRH1 p.R31C mutation, reported in the literature as pathogenic and dominant. The same mutation was found in his son at birth, but the testing of the infant at 64 days confirmed the hormonal changes associated with minipuberty. This led to further genetic sequencing of the patient and his son, which found a second variant, AMHR2 p.G445_L453del, in the heterozygous form, reported as pathogenic in the patient but not in his son. This suggests a digenic cause of the patient’s CHH. Together, these mutations are postulated to contribute to CHH by the lack of anti-Müllerian hormone (AMH) signalling, leading to the impaired migration of gonadotrophin releasing hormone (GnRH) neurons, the lack of the AMH effect on GnRH secretion, and altered GnRH decapeptide with reduced binding to GnRH receptors. This led us to the conclusion that the observed GNRH1 mutation in the heterozygous state is not certain to be dominant or, at least, exhibits incomplete penetrance and variable expressivity. This report also emphasises the opportunity afforded by the time window of minipuberty in assessing the inherited genetic disorders of hypothalamic function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gonadotropin-Releasing HormoneHypogonadismAdultHumansInfantMaleHeterozygoteMutationNeuronsProtein Serine-Threonine Kinases

Stichwörter der Autor:innen

AMHR2GNRH1Kallmann syndromecongenital hypogonadotropic hypogonadismminipuberty

Substanzen

Gonadotropin-Releasing HormoneProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Keogh Institute for Medical Research, Nedlands, WA 6009, Australia.
  • Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.
  • Medical School, University of Western Australia, Nedlands, WA 6009, Australia.
  • Telethon Kids Institute, Nedlands, WA 6009, Australia.
  • Perth Children's Hospital, Nedlands, WA 6009, Australia.
  • Harry Perkins Institute for Medical Research and Centre for Medical Research, University of Western Australia, Nedlands, WA 6009, Australia.

ORCID-Profile: Scott G Wilson

Zitieren

APA

Stuckey, B. G. A., Jones, T. W., Ward, B. K., & Wilson, S. G. (2023). Digenic Congenital Hypogonadotropic Hypogonadism Due to Heterozygous GNRH1 p.R31C and AMHR2 p.G445_L453del Variants. Genes. https://doi.org/10.3390/genes14061204

Vancouver

Stuckey BGA, Jones TW, Ward BK, Wilson SG. Digenic Congenital Hypogonadotropic Hypogonadism Due to Heterozygous GNRH1 p.R31C and AMHR2 p.G445_L453del Variants. Genes. 2023. doi:10.3390/genes14061204

BibTeX
@article{Stuckey2023,
  author = {Stuckey, Bronwyn G A and Jones, Timothy W and Ward, Bryan K and Wilson, Scott G},
  title = {Digenic Congenital Hypogonadotropic Hypogonadism Due to Heterozygous GNRH1 p.R31C and AMHR2 p.G445_L453del Variants},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14061204}
}
Kostenlos starten →